Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:09:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to replace Revision: v3.4.1 on the page. This appears to be a minor site version update not affecting study details.
    Difference
    0.0%
    Check dated 2026-02-12T02:06:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. The change is a minor deployment note and does not modify study content, navigation, or displayed data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:47:36.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    This update adds a glossary toggle and a revision label (v3.4.0), and adjusts QC-related headers and FEAR Act terminology.
    Difference
    0.1%
    Check dated 2026-01-28T20:22:26.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Updated page revision from v3.3.3 to v3.3.4 with no visible impact on content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:05:13.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The study's Locations section has been expanded and reorganized to list participating sites across multiple countries and regions.
    Difference
    3%
    Check dated 2025-12-23T21:19:31.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.